Preparation and characterization of polyethylenimine‐coated Fe3O4‐MCM‐48 nanocomposite particles as a novel agent for magnet‐assisted transfection
- 3 February 2009
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 92A (1), 386-392
- https://doi.org/10.1002/jbm.a.32363
Abstract
A new type of magnetic nanoparticle was synthesized using mesoporous silica MCM-48 as a template. Magnetite (Fe3O4) nanocrystals were incorporated onto the MCM-48 silica structure by thermal decomposition of iron(III) acetylacetonate. The particle size of these Fe3O4-MCM-48 composite particles is around 300 nm with an iron oxide content of ca. 20% w/w. Measurements from SQUID magnetometry suggest that these nanoparticles possess superparamagnetic properties similar to those of Fe3O4 nanoparticles. By coating positively charged polyethylenimine on to the surface, DNA can be bound onto the Fe3O4-MCM-48 nanoparticles. Transfection studies showed that these PEI-Fe3O4-MCM-48 particles were highly effective as a transfection reagent, and a 400% increase of transfection efficiency compared with the commercial products was recorded. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010Keywords
This publication has 35 references indexed in Scilit:
- Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfectionJournal of Materials Chemistry, 2007
- Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticlesThe FASEB Journal, 2007
- DNA delivery using polyethyleneimine (PEI) coated iron oxide-silica mesostructured particles.Published by Elsevier BV ,2007
- Monodisperse MFe2O4 (M = Fe, Co, Mn) NanoparticlesJournal of the American Chemical Society, 2003
- A Degradable Polyethylenimine Derivative with Low Toxicity for Highly Efficient Gene DeliveryBioconjugate Chemistry, 2003
- Non-viral and hybrid vectors in human gene therapy: an updateTrends in Molecular Medicine, 2003
- Improved Method of Recombinant AAV2 Delivery for Systemic Targeted Gene TherapyMolecular Therapy, 2002
- Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivoGene Therapy, 2002
- Enzyme immobilisation using siliceous mesoporous molecular sievesMicroporous and Mesoporous Materials, 2001
- Development of Biomaterials for Gene TherapyMolecular Therapy, 2000